Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 184

1.

Maximum Reading Speed in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration.

Varma R, Souied EH, Tufail A, Tschosik E, Ferrara D, Zhang J, Silverman D, Dolan C, Bressler NM.

Invest Ophthalmol Vis Sci. 2018 Mar 20;59(4):AMD195-AMD201. doi: 10.1167/iovs.18-24238.

PMID:
30383205
2.

Reply.

Lee A, Taylor P, Kalpathy-Cramer J, Tufail A.

Ophthalmology. 2018 Oct 18. pii: S0161-6420(18)30482-2. doi: 10.1016/j.ophtha.2018.06.036. [Epub ahead of print] No abstract available.

PMID:
30343936
3.

Retinopathy Associated with Biallelic Mutations in PYGM (McArdle Disease).

Mahroo OA, Khan KN, Wright G, Ockrim Z, Scalco RS, Robson AG, Tufail A, Michaelides M, Quinlivan R, Webster AR.

Ophthalmology. 2018 Oct 10. pii: S0161-6420(18)32259-0. doi: 10.1016/j.ophtha.2018.09.013. [Epub ahead of print] No abstract available.

4.

United Kingdom Diabetic Retinopathy Electronic Medical Record (UK DR EMR) Users Group: report 4, real-world data on the impact of deprivation on the presentation of diabetic eye disease at hospital services.

Denniston AK, Lee AY, Lee CS, Crabb DP, Bailey C, Lip PL, Taylor P, Pikoula M, Cook E, Akerele T, Antcliff R, Brand C, Chakravarthy U, Chavan R, Dhingra N, Downey L, Eleftheriadis H, Ghanchi F, Khan R, Kumar V, Lobo A, Lotery A, Menon G, Mukherjee R, Palmer H, Patra S, Paul B, Sim DA, Talks JS, Wilkinson E, Tufail A, Egan CA.

Br J Ophthalmol. 2018 Sep 29. pii: bjophthalmol-2018-312568. doi: 10.1136/bjophthalmol-2018-312568. [Epub ahead of print]

5.

Interdevice variability of central corneal thickness measurement.

Maloca PM, Studer HP, Ambrósio R Jr, Goldblum D, Rothenbuehler S, Barthelmes D, Zweifel S, Scholl HPN, Balaskas K, Tufail A, Hasler PW.

PLoS One. 2018 Sep 13;13(9):e0203884. doi: 10.1371/journal.pone.0203884. eCollection 2018.

6.

MACUSTAR: Development and Clinical Validation of Functional, Structural, and Patient-Reported Endpoints in Intermediate Age-Related Macular Degeneration.

Finger RP, Schmitz-Valckenberg S, Schmid M, Rubin GS, Dunbar H, Tufail A, Crabb DP, Binns A, Sánchez CI, Margaron P, Normand G, Durbin MK, Luhmann UFO, Zamiri P, Cunha-Vaz J, Asmus F, Holz FG; on behalf of the MACUSTAR consortium.

Ophthalmologica. 2018 Aug 28:1-12. doi: 10.1159/000491402. [Epub ahead of print]

7.

Clinically applicable deep learning for diagnosis and referral in retinal disease.

De Fauw J, Ledsam JR, Romera-Paredes B, Nikolov S, Tomasev N, Blackwell S, Askham H, Glorot X, O'Donoghue B, Visentin D, van den Driessche G, Lakshminarayanan B, Meyer C, Mackinder F, Bouton S, Ayoub K, Chopra R, King D, Karthikesalingam A, Hughes CO, Raine R, Hughes J, Sim DA, Egan C, Tufail A, Montgomery H, Hassabis D, Rees G, Back T, Khaw PT, Suleyman M, Cornebise J, Keane PA, Ronneberger O.

Nat Med. 2018 Sep;24(9):1342-1350. doi: 10.1038/s41591-018-0107-6. Epub 2018 Aug 13.

PMID:
30104768
8.

Safety and Feasibility of a Novel Sparse Optical Coherence Tomography Device for Patient-Delivered Retina Home Monitoring.

Maloca P, Hasler PW, Barthelmes D, Arnold P, Matthias M, Scholl HPN, Gerding H, Garweg J, Heeren T, Balaskas K, de Carvalho JER, Egan C, Tufail A, Zweifel SA.

Transl Vis Sci Technol. 2018 Jul 24;7(4):8. doi: 10.1167/tvst.7.4.8. eCollection 2018 Jul.

9.

High-Performance Virtual Reality Volume Rendering of Original Optical Coherence Tomography Point-Cloud Data Enhanced With Real-Time Ray Casting.

Maloca PM, de Carvalho JER, Heeren T, Hasler PW, Mushtaq F, Mon-Williams M, Scholl HPN, Balaskas K, Egan C, Tufail A, Witthauer L, Cattin PC.

Transl Vis Sci Technol. 2018 Jul 9;7(4):2. doi: 10.1167/tvst.7.4.2. eCollection 2018 Jul.

10.

Three-Year Outcomes of Aflibercept Treatment for Neovascular Age-Related Macular Degeneration: Evidence from a Clinical Setting.

Eleftheriadou M, Gemenetzi M, Lukic M, Sivaprasad S, Hykin PG, Hamilton RD, Rajendram R, Tufail A, Patel PJ.

Ophthalmol Ther. 2018 Jul 7. doi: 10.1007/s40123-018-0139-5. [Epub ahead of print]

PMID:
29982914
11.

Efficacy and Safety of Lampalizumab for Geographic Atrophy Due to Age-Related Macular Degeneration: Chroma and Spectri Phase 3 Randomized Clinical Trials.

Holz FG, Sadda SR, Busbee B, Chew EY, Mitchell P, Tufail A, Brittain C, Ferrara D, Gray S, Honigberg L, Martin J, Tong B, Ehrlich JS, Bressler NM; Chroma and Spectri Study Investigators.

JAMA Ophthalmol. 2018 Jun 1;136(6):666-677. doi: 10.1001/jamaophthalmol.2018.1544.

12.

Heavy metal accumulation imparts structural differences in fragrant Rosa species irrigated with marginal quality water.

Ahsan M, Younis A, Jaskani MJ, Tufail A, Riaz A, Schwinghamer T, Tariq U, Nawaz F.

Ecotoxicol Environ Saf. 2018 Sep 15;159:240-248. doi: 10.1016/j.ecoenv.2018.05.003. Epub 2018 May 21.

PMID:
29753826
13.

A 12-month, multicenter, parallel group comparison of dexamethasone intravitreal implant versus ranibizumab in branch retinal vein occlusion.

Bandello F, Augustin A, Tufail A, Leaback R.

Eur J Ophthalmol. 2018 Nov;28(6):697-705. doi: 10.1177/1120672117750058. Epub 2018 Apr 9.

PMID:
29631435
14.

Phase 1 clinical study of an embryonic stem cell-derived retinal pigment epithelium patch in age-related macular degeneration.

da Cruz L, Fynes K, Georgiadis O, Kerby J, Luo YH, Ahmado A, Vernon A, Daniels JT, Nommiste B, Hasan SM, Gooljar SB, Carr AF, Vugler A, Ramsden CM, Bictash M, Fenster M, Steer J, Harbinson T, Wilbrey A, Tufail A, Feng G, Whitlock M, Robson AG, Holder GE, Sagoo MS, Loudon PT, Whiting P, Coffey PJ.

Nat Biotechnol. 2018 Apr;36(4):328-337. doi: 10.1038/nbt.4114. Epub 2018 Mar 19.

PMID:
29553577
15.

COMPARING FUNDUS FLUORESCEIN ANGIOGRAPHY AND SWEPT-SOURCE OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY IN THE EVALUATION OF DIABETIC MACULAR PERFUSION.

La Mantia A, Kurt RA, Mejor S, Egan CA, Tufail A, Keane PA, Sim DA.

Retina. 2018 Jan 16. doi: 10.1097/IAE.0000000000002045. [Epub ahead of print]

PMID:
29346244
16.

Real-world outcomes in patients with neovascular age-related macular degeneration treated with intravitreal vascular endothelial growth factor inhibitors.

Mehta H, Tufail A, Daien V, Lee AY, Nguyen V, Ozturk M, Barthelmes D, Gillies MC.

Prog Retin Eye Res. 2018 Jul;65:127-146. doi: 10.1016/j.preteyeres.2017.12.002. Epub 2018 Jan 2. Review.

17.

3D printing of the choroidal vessels and tumours based on optical coherence tomography.

Maloca PM, Tufail A, Hasler PW, Rothenbuehler S, Egan C, Ramos de Carvalho JE, Spaide RF.

Acta Ophthalmol. 2017 Dec 14. doi: 10.1111/aos.13637. [Epub ahead of print] No abstract available.

PMID:
29240288
18.

Machine Learning Has Arrived!

Lee A, Taylor P, Kalpathy-Cramer J, Tufail A.

Ophthalmology. 2017 Dec;124(12):1726-1728. doi: 10.1016/j.ophtha.2017.08.046. No abstract available.

PMID:
29157423
19.

Leaf cell membrane stability-based mechanisms of zinc nutrition in mitigating salinity stress in rice.

Tufail A, Li H, Naeem A, Li TX.

Plant Biol (Stuttg). 2018 Mar;20(2):338-345. doi: 10.1111/plb.12665. Epub 2017 Dec 13.

PMID:
29148143
20.

Enhanced resolution and speckle-free three-dimensional printing of macular optical coherence tomography angiography.

Maloca PM, Spaide RF, Rothenbuehler S, Scholl HPN, Heeren T, Ramos de Carvalho JE, Okada M, Hasler PW, Egan C, Tufail A.

Acta Ophthalmol. 2017 Nov 13. doi: 10.1111/aos.13567. [Epub ahead of print] No abstract available.

21.

Consensus Definition for Atrophy Associated with Age-Related Macular Degeneration on OCT: Classification of Atrophy Report 3.

Sadda SR, Guymer R, Holz FG, Schmitz-Valckenberg S, Curcio CA, Bird AC, Blodi BA, Bottoni F, Chakravarthy U, Chew EY, Csaky K, Danis RP, Fleckenstein M, Freund KB, Grunwald J, Hoyng CB, Jaffe GJ, Liakopoulos S, Monés JM, Pauleikhoff D, Rosenfeld PJ, Sarraf D, Spaide RF, Tadayoni R, Tufail A, Wolf S, Staurenghi G.

Ophthalmology. 2018 Apr;125(4):537-548. doi: 10.1016/j.ophtha.2017.09.028. Epub 2017 Nov 2.

PMID:
29103793
22.

Perspective Research Progress in Cold Responses of Capsella bursa-pastoris.

Noman A, Kanwal H, Khalid N, Sanaullah T, Tufail A, Masood A, Sabir SU, Aqeel M, He S.

Front Plant Sci. 2017 Aug 14;8:1388. doi: 10.3389/fpls.2017.01388. eCollection 2017. Review.

23.

Clinical audit in retina 2016: Chairman's introduction.

Tufail A.

Eye (Lond). 2017 Aug;31(S2):S1. doi: 10.1038/eye.2017.146. No abstract available.

24.

Cost-effectiveness of age-related macular degeneration study supplements in the UK: combined trial and real-world outcomes data.

Lee AY, Butt T, Chew E, Agron E, Clemons TE, Egan CA, Lee CS, Tufail A; UK EMR AMD Research Group.

Br J Ophthalmol. 2018 Apr;102(4):465-472. doi: 10.1136/bjophthalmol-2017-310939. Epub 2017 Aug 23.

PMID:
28835423
25.

MACULAR TELANGIECTASIA TYPE 2: Quantitative Analysis of a Novel Phenotype and Implications for the Pathobiology of the Disease.

Okada M, Egan CA, Heeren TFC, Tufail A, Fruttiger M, Maloca PM.

Retina. 2018 Jan;38 Suppl 1:S97-S104. doi: 10.1097/IAE.0000000000001812.

PMID:
28834952
26.

The United Kingdom Diabetic Retinopathy Electronic Medical Record Users Group: Report 3: Baseline Retinopathy and Clinical Features Predict Progression of Diabetic Retinopathy.

Lee CS, Lee AY, Baughman D, Sim D, Akelere T, Brand C, Crabb DP, Denniston AK, Downey L, Fitt A, Khan R, Mahmood S, Mandal K, Mckibbin M, Menon G, Lobo A, Kumar BV, Natha S, Varma A, Wilkinson E, Mitry D, Bailey C, Chakravarthy U, Tufail A, Egan C; UK DR EMR Users Group.

Am J Ophthalmol. 2017 Aug;180:64-71. doi: 10.1016/j.ajo.2017.05.020. Epub 2017 May 29.

27.

THREE-DIMENSIONAL ANALYSIS OF SUBMACULAR PERFORATING SCLERAL VESSELS BY ENHANCED DEPTH IMAGING OPTICAL COHERENCE TOMOGRAPHY.

Rothenbuehler SP, Maloca P, Scholl HPN, Gyger C, Schoetzau A, Kuske L, Mosimann N, Zweifel SA, Barthelmes D, Tufail A, Hasler PW.

Retina. 2018 Jun;38(6):1231-1237. doi: 10.1097/IAE.0000000000001686.

28.

The UK Diabetic Retinopathy Electronic Medical Record (UK DR EMR) Users Group, Report 2: real-world data for the impact of cataract surgery on diabetic macular oedema.

Denniston AK, Chakravarthy U, Zhu H, Lee AY, Crabb DP, Tufail A, Bailey C, Akerele T, Al-Husainy S, Brand C, Downey L, Fitt A, Khan R, Kumar V, Lobo A, Mahmood S, Mandal K, Mckibbin M, Menon G, Natha S, Ong JM, Tsaloumas MD, Varma A, Wilkinson E, Johnston RL, Egan CA; UK DR EMR Users Group.

Br J Ophthalmol. 2017 Dec;101(12):1673-1678. doi: 10.1136/bjophthalmol-2016-309838. Epub 2017 May 9.

PMID:
28487377
29.

UK AMD/DR EMR REPORT IX: comparative effectiveness of predominantly as needed (PRN) ranibizumab versus continuous aflibercept in UK clinical practice.

Lee AY, Lee CS, Egan CA, Bailey C, Johnston RL, Natha S, Hamilton R, Khan R, Al-Husainy S, Brand C, Akerele T, Mckibbin M, Downey L, Tufail A.

Br J Ophthalmol. 2017 Dec;101(12):1683-1688. doi: 10.1136/bjophthalmol-2016-309818. Epub 2017 May 6.

PMID:
28478396
30.

Characteristics and racial variations of polypoidal choroidal vasculopathy in tertiary centers in the United States and United Kingdom.

Alasil T, Munoz N, Keane PA, Tufail A, Coady PA, Novais E, de Carlo TE, Baumal CR, Waheed NK, Duker JS, Adelman RA.

Int J Retina Vitreous. 2017 Apr 17;3:9. doi: 10.1186/s40942-017-0060-4. eCollection 2017.

31.

VISUAL ACUITY IMPROVEMENT WHEN SWITCHING FROM RANIBIZUMAB TO AFLIBERCEPT IS NOT SUSTAINED.

Lee CS, Kim AJ, Baughman D, Egan C, Bailey C, Johnston RL, Natha S, Khan R, Brand C, Akerele T, McKibbin M, Downey L, Al-Husainy S, Lee AY, Tufail A.

Retina. 2018 May;38(5):951-956. doi: 10.1097/IAE.0000000000001637.

PMID:
28406859
32.

Imaging Protocols in Clinical Studies in Advanced Age-Related Macular Degeneration: Recommendations from Classification of Atrophy Consensus Meetings.

Holz FG, Sadda SR, Staurenghi G, Lindner M, Bird AC, Blodi BA, Bottoni F, Chakravarthy U, Chew EY, Csaky K, Curcio CA, Danis R, Fleckenstein M, Freund KB, Grunwald J, Guymer R, Hoyng CB, Jaffe GJ, Liakopoulos S, Monés JM, Oishi A, Pauleikhoff D, Rosenfeld PJ, Sarraf D, Spaide RF, Tadayoni R, Tufail A, Wolf S, Schmitz-Valckenberg S; CAM group.

Ophthalmology. 2017 Apr;124(4):464-478. doi: 10.1016/j.ophtha.2016.12.002. Epub 2017 Jan 18.

PMID:
28109563
33.

Automated Diabetic Retinopathy Image Assessment Software: Diagnostic Accuracy and Cost-Effectiveness Compared with Human Graders.

Tufail A, Rudisill C, Egan C, Kapetanakis VV, Salas-Vega S, Owen CG, Lee A, Louw V, Anderson J, Liew G, Bolter L, Srinivas S, Nittala M, Sadda S, Taylor P, Rudnicka AR.

Ophthalmology. 2017 Mar;124(3):343-351. doi: 10.1016/j.ophtha.2016.11.014. Epub 2016 Dec 23.

34.

An observational study to assess if automated diabetic retinopathy image assessment software can replace one or more steps of manual imaging grading and to determine their cost-effectiveness.

Tufail A, Kapetanakis VV, Salas-Vega S, Egan C, Rudisill C, Owen CG, Lee A, Louw V, Anderson J, Liew G, Bolter L, Bailey C, Sadda S, Taylor P, Rudnicka AR.

Health Technol Assess. 2016 Dec;20(92):1-72.

35.

The United Kingdom Diabetic Retinopathy Electronic Medical Record Users Group, Report 1: baseline characteristics and visual acuity outcomes in eyes treated with intravitreal injections of ranibizumab for diabetic macular oedema.

Egan C, Zhu H, Lee A, Sim D, Mitry D, Bailey C, Johnston R, Chakravarthy U, Denniston A, Tufail A, Khan R, Mahmood S, Menon G, Akerele T, Downey L, McKibbin M, Varma A, Lobo A, Wilkinson E, Fitt A, Brand C, Tsaloumas M, Mandal K, Kumar V, Natha S, Crabb D; UK AMD and DR EMR Users Group.

Br J Ophthalmol. 2017 Jan;101(1):75-80. doi: 10.1136/bjophthalmol-2016-309313. Epub 2016 Dec 13.

PMID:
27965262
36.

Optical coherence tomography angiography of foveal hypoplasia.

Pakzad-Vaezi K, Keane PA, Cardoso JN, Egan C, Tufail A.

Br J Ophthalmol. 2017 Jul;101(7):985-988. doi: 10.1136/bjophthalmol-2016-309200. Epub 2016 Nov 29.

PMID:
27899366
37.

Natural history and effect of therapeutic interventions on subretinal fluid causing foveal detachment in macular telangiectasia type 2.

Mehta H, Müller S, Egan CA, Degli Esposti S, Tufail A, Sim DA, Holz FG, Browning AC, Amoaku WM, Charbel Issa P, Gillies MC.

Br J Ophthalmol. 2017 Jul;101(7):955-959. doi: 10.1136/bjophthalmol-2016-309237. Epub 2016 Oct 28.

PMID:
27793821
38.

Big Data and Uveitis.

Lee CS, Lee AY, Holland GN, Van Gelder RN, Tufail A.

Ophthalmology. 2016 Nov;123(11):2273-2275. doi: 10.1016/j.ophtha.2016.08.037. No abstract available.

39.

UK Age-Related Macular Degeneration Electronic Medical Record System (AMD EMR) Users Group Report IV: Incidence of Blindness and Sight Impairment in Ranibizumab-Treated Patients.

Johnston RL, Lee AY, Buckle M, Antcliff R, Bailey C, McKibbin M, Chakravarthy U, Tufail A; UK AMD EMR Users Group.

Ophthalmology. 2016 Nov;123(11):2386-2392. doi: 10.1016/j.ophtha.2016.07.037. Epub 2016 Sep 9.

PMID:
27615601
40.

Associations with Retinal Pigment Epithelium Thickness Measures in a Large Cohort: Results from the UK Biobank.

Ko F, Foster PJ, Strouthidis NG, Shweikh Y, Yang Q, Reisman CA, Muthy ZA, Chakravarthy U, Lotery AJ, Keane PA, Tufail A, Grossi CM, Patel PJ; UK Biobank Eye & Vision Consortium.

Ophthalmology. 2017 Jan;124(1):105-117. doi: 10.1016/j.ophtha.2016.07.033. Epub 2016 Oct 6.

PMID:
27720551
41.

Evaluation of Nonperfused Retinal Vessels in Ischemic Retinopathy.

Powner MB, Sim DA, Zhu M, Nobre-Cardoso J, Jones R, Syed A, Chang AA, Keane PA, Tufail A, Egan CA, Fruttiger M.

Invest Ophthalmol Vis Sci. 2016 Sep 1;57(11):5031-5037. doi: 10.1167/iovs.16-20007.

PMID:
27661854
42.

Health State Utility Values for Age-Related Macular Degeneration: Review and Advice.

Butt T, Tufail A, Rubin G.

Appl Health Econ Health Policy. 2017 Feb;15(1):23-32. doi: 10.1007/s40258-016-0275-9. Review.

PMID:
27637920
43.

Repeatability of swept-source optical coherence tomography retinal and choroidal thickness measurements in neovascular age-related macular degeneration.

Hanumunthadu D, Ilginis T, Restori M, Sagoo MS, Tufail A, Balaggan KS, Patel PJ.

Br J Ophthalmol. 2017 May;101(5):603-608. doi: 10.1136/bjophthalmol-2016-308999. Epub 2016 Aug 4.

PMID:
27491359
44.

The UK Neovascular AMD Database Report 3: inter-centre variation in visual acuity outcomes and establishing real-world measures of care.

Liew G, Lee AY, Zarranz-Ventura J, Stratton I, Bunce C, Chakravarthy U, Lee CS, Keane PA, Sim DA, Akerele T, McKibbin M, Downey L, Natha S, Bailey C, Khan R, Antcliff R, Armstrong S, Varma A, Kumar V, Tsaloumas M, Mandal K, Egan C, Johnston RL, Tufail A.

Eye (Lond). 2016 Nov;30(11):1462-1468. doi: 10.1038/eye.2016.149. Epub 2016 Jul 15.

45.

Use of Mechanical Turk as a MapReduce Framework for Macular OCT Segmentation.

Lee AY, Lee CS, Keane PA, Tufail A.

J Ophthalmol. 2016;2016:6571547. doi: 10.1155/2016/6571547. Epub 2016 May 11.

46.

Ranibizumab in Myopic Choroidal Neovascularization: A Subgroup Analysis by Ethnicity, Age, and Ocular Characteristics in RADIANCE.

Holz FG, Tufail A, Leveziel N, Lai TY, Lanzetta P, Wong TY, Yu HG, Chen YX, Heinrichs N, Pilz S, Ohno-Matsui K; RADIANCE Study Group.

Ophthalmologica. 2016;236(1):19-28. doi: 10.1159/000446027. Epub 2016 Jun 7.

PMID:
27270597
47.

Differentiating drusen: Drusen and drusen-like appearances associated with ageing, age-related macular degeneration, inherited eye disease and other pathological processes.

Khan KN, Mahroo OA, Khan RS, Mohamed MD, McKibbin M, Bird A, Michaelides M, Tufail A, Moore AT.

Prog Retin Eye Res. 2016 Jul;53:70-106. doi: 10.1016/j.preteyeres.2016.04.008. Epub 2016 May 10. Review.

PMID:
27173377
48.

Defining a Minimum Set of Standardized Patient-centered Outcome Measures for Macular Degeneration.

Rodrigues IA, Sprinkhuizen SM, Barthelmes D, Blumenkranz M, Cheung G, Haller J, Johnston R, Kim R, Klaver C, McKibbin M, Ngah NF, Pershing S, Shankar D, Tamura H, Tufail A, Weng CY, Westborg I, Yelf C, Yoshimura N, Gillies MC.

Am J Ophthalmol. 2016 Aug;168:1-12. doi: 10.1016/j.ajo.2016.04.012. Epub 2016 Apr 27.

49.

Spectral-domain Optical Coherence Tomography Retinal and Choroidal Thickness Metric Repeatability in Age-related Macular Degeneration.

Hanumunthadu D, Ilginis T, Restori M, Sagoo M, Tufail A, Balaggan KS, Patel PJ.

Am J Ophthalmol. 2016 Jun;166:154-161. doi: 10.1016/j.ajo.2016.03.052. Epub 2016 Apr 9.

PMID:
27066726
50.

UK Neovascular Age-Related Macular Degeneration Database. Report 6: time to retreatment after a pause in therapy. Outcomes from 92 976 intravitreal ranibizumab injections.

Madhusudhana KC, Lee AY, Keane PA, Chakravarthy U, Johnston RL, Egan CA, Sim D, Zarranz-Ventura J, Tufail A, McKibbin M; UK AMD EMR Study Group.

Br J Ophthalmol. 2016 Dec;100(12):1617-1622. doi: 10.1136/bjophthalmol-2015-308077. Epub 2016 Mar 30.

PMID:
27030276

Supplemental Content

Loading ...
Support Center